DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
XRAY logo

DENTSPLY SIRONA Inc. Stock Price

NasdaqGS:XRAY Community·US$2.1b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 27 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

XRAY Share Price Performance

US$10.50
-3.44 (-24.68%)
​
US$13.40
Fair Value
US$10.50
-3.44 (-24.68%)
21.6% undervalued intrinsic discount
US$13.40
Fair Value
Price US$10.50
AnalystConsensusTarget US$13.40
AnalystLowTarget US$10.50
AnalystHighTarget US$17.00
Mon, 29 Jun 26
Fair ValueUS$13.40
Share Pricen/a

XRAY Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$13.4 21.6% undervalued intrinsic discount

Analysts Weigh Mixed Outlook for DENTSPLY SIRONA as Valuation and Guidance Adjusted

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$10.5 Fairly Valued intrinsic discount

Rising Cost Pressures And Market Shifts Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$17 38.2% undervalued intrinsic discount

An Aging Population And Emerging Markets Will Fuel Digital Dentistry

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
XRAY logo
DENTSPLY SIRONA
76.9% undervalued intrinsic discount

Dentsply Sirona Stock: Dental Technology Built for Cycles, Not Headlines

View narrative
YI
yiannisz
Updated 30 Jan
Read Narrative
XRAY logo
DENTSPLY SIRONA
Fairly Valued intrinsic discount

Rising Cost Pressures And Market Shifts Will Erode Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 22 Aug
Read Narrative
XRAY logo
DENTSPLY SIRONA
21.6% undervalued intrinsic discount

Analysts Weigh Mixed Outlook for DENTSPLY SIRONA as Valuation and Guidance Adjusted

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 29 Jun
Read Narrative
XRAY logo
DENTSPLY SIRONA
38.2% undervalued intrinsic discount

An Aging Population And Emerging Markets Will Fuel Digital Dentistry

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 1 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

YI
XRAY logo

Dentsply Sirona Stock: Dental Technology Built for Cycles, Not Headlines

Fair Value: US$45.5 76.9% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
XRAY logo

XRAY: Turnaround Progress And Execution Risks Will Likely Keep Upside Measured

Fair Value: US$10.5 Fairly Valued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
XRAY logo

XRAY: Reset Expectations And Product Execution Will Shape 2026 Rebound Potential

Fair Value: US$13.4 21.6% undervalued intrinsic discount
10 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Very undervalued with moderate growth potential.

0 Risks
4 Rewards
View Full Analysis

DENTSPLY SIRONA Inc. Key Details

US$3.6b

Revenue

US$1.8b

Cost of Revenue

US$1.8b

Gross Profit

US$2.4b

Other Expenses

-US$546.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-2.74
49.52%
-14.99%
165.7%
View Full Analysis

About XRAY

Founded
1877
Employees
14000
CEO
Daniel Scavilla
WebsiteView website
www.dentsplysirona.com

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Recent XRAY News & Updates

User avatar
Narrative Update • Aug 22

XRAY: Turnaround Progress And Execution Risks Will Likely Keep Upside Measured

Dentsply Sirona's updated analyst price target of $10.50, compared with the prior fair value estimate of $9.42, reflects analysts balancing gradual optimism around the turnaround plan with continued caution on execution timing and near term catalysts following recent mixed target revisions on the Street. Analyst Commentary Recent Street research around Dentsply Sirona points to a cautious tone, even as some targets move higher.
User avatar
Narrative Update • Aug 08

XRAY: Turnaround Execution Concerns Will Likely Cap Upside For Now

Analysts have nudged their fair value estimate for DENTSPLY SIRONA slightly higher, with the updated price target moving from about $9.00 to roughly $9.42. This change reflects recent price target revisions, a lower discount rate, and mixed views on the timing of any potential turnaround benefits.

Recent updates

No updates

DENTSPLY SIRONA Inc. Competitors

BAX logo

Baxter International

Symbol: NYSE:BAX
Market cap: US$12.6b
PEN logo

Penumbra

Symbol: NYSE:PEN
Market cap: US$12.6b
COO logo

Cooper Companies

Symbol: NasdaqGS:COO
Market cap: US$12.1b
EHC logo

Encompass Health

Symbol: NYSE:EHC
Market cap: US$12.0b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide